HLS Therapeutics Inc. (HLS.TO)
CAD 3.62
(0.56%)
CAD 3.62
(0.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 87.62 Million USD | -9.99% |
| 2022 | 97.34 Million USD | -0.23% |
| 2021 | 97.56 Million USD | -8.92% |
| 2020 | 107.12 Million USD | 15.05% |
| 2019 | 93.11 Million USD | -3.72% |
| 2018 | 96.7 Million USD | -29.26% |
| 2017 | 136.7 Million USD | -6.39% |
| 2016 | 146.04 Million USD | -10.36% |
| 2015 | 162.93 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 333 Thousand USD | -52.28% |
| 2010 | 697.88 Thousand USD | -92.11% |
| 2009 | 8.84 Million USD | -8.18% |
| 2008 | 9.63 Million USD | -30.66% |
| 2007 | 13.89 Million USD | 19.98% |
| 2006 | 11.58 Million USD | 171.59% |
| 2005 | 4.26 Million USD | -38.92% |
| 2004 | 6.98 Million USD | 129.41% |
| 2003 | 3.04 Million USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 1.94 Million USD | -71.92% |
| 2000 | 6.91 Million USD | -29.44% |
| 1999 | 9.8 Million USD | 22.65% |
| 1998 | 7.99 Million USD | -5.46% |
| 1997 | 8.45 Million USD | 119.16% |
| 1996 | 3.85 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 83.07 Million USD | -2.38% |
| 2024 Q1 | 85.09 Million USD | -2.88% |
| 2023 FY | 87.62 Million USD | -9.99% |
| 2023 Q1 | 95.19 Million USD | -2.21% |
| 2023 Q2 | 94.07 Million USD | -1.18% |
| 2023 Q3 | 90.73 Million USD | -3.55% |
| 2023 Q4 | 87.62 Million USD | -3.43% |
| 2022 FY | 97.34 Million USD | -0.23% |
| 2022 Q2 | 91.63 Million USD | -3.16% |
| 2022 Q1 | 94.62 Million USD | -3.01% |
| 2022 Q3 | 99.7 Million USD | 8.81% |
| 2022 Q4 | 97.34 Million USD | -2.37% |
| 2021 Q1 | 104.96 Million USD | -2.01% |
| 2021 FY | 97.56 Million USD | -8.92% |
| 2021 Q3 | 100.03 Million USD | -2.72% |
| 2021 Q4 | 97.56 Million USD | -2.46% |
| 2021 Q2 | 102.83 Million USD | -2.03% |
| 2020 Q1 | 91.71 Million USD | -1.5% |
| 2020 Q4 | 107.12 Million USD | -1.79% |
| 2020 FY | 107.12 Million USD | 15.05% |
| 2020 Q3 | 109.07 Million USD | 20.44% |
| 2020 Q2 | 90.56 Million USD | -1.26% |
| 2019 Q1 | 96.51 Million USD | -0.2% |
| 2019 Q4 | 93.11 Million USD | -1.24% |
| 2019 FY | 93.11 Million USD | -3.72% |
| 2019 Q2 | 95.31 Million USD | -1.24% |
| 2019 Q3 | 94.27 Million USD | -1.09% |
| 2018 FY | 96.7 Million USD | -29.26% |
| 2018 Q1 | 130.56 Million USD | -4.49% |
| 2018 Q2 | 125.25 Million USD | -4.07% |
| 2018 Q3 | 97.81 Million USD | -21.9% |
| 2018 Q4 | 96.7 Million USD | -1.14% |
| 2017 FY | 136.7 Million USD | -6.39% |
| 2017 Q4 | 136.7 Million USD | -2.56% |
| 2017 Q3 | 140.29 Million USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | 146.04 Million USD | 0.0% |
| 2016 FY | 146.04 Million USD | -10.36% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | 162.93 Million USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | -100.0% |
| 2012 Q3 | 35.56 Thousand USD | -74.35% |
| 2012 FY | - USD | -100.0% |
| 2012 Q2 | 138.62 Thousand USD | -42.61% |
| 2012 Q1 | 241.55 Thousand USD | -27.46% |
| 2011 Q3 | 424.01 Thousand USD | -5.38% |
| 2011 Q2 | 448.1 Thousand USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 FY | 333 Thousand USD | -52.28% |
| 2011 Q4 | 333 Thousand USD | -21.46% |
| 2010 Q2 | 381.36 Thousand USD | -62.11% |
| 2010 Q3 | 370.22 Thousand USD | -2.92% |
| 2010 Q4 | 697.88 Thousand USD | 88.5% |
| 2010 Q1 | 1 Million USD | -88.62% |
| 2010 FY | 697.88 Thousand USD | -92.11% |
| 2009 Q4 | 8.84 Million USD | 190.5% |
| 2009 FY | 8.84 Million USD | -8.18% |
| 2009 Q1 | 8.88 Million USD | -7.73% |
| 2009 Q2 | 9.2 Million USD | 3.58% |
| 2009 Q3 | 3.04 Million USD | -66.93% |
| 2008 FY | 9.63 Million USD | -30.66% |
| 2008 Q4 | 9.63 Million USD | -17.02% |
| 2008 Q1 | 13.01 Million USD | -6.29% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q3 | 11.61 Million USD | 0.0% |
| 2007 Q4 | 13.89 Million USD | 153.19% |
| 2007 Q2 | 7.39 Million USD | -15.81% |
| 2007 Q1 | 8.77 Million USD | -24.19% |
| 2007 FY | 13.89 Million USD | 19.98% |
| 2007 Q3 | 5.48 Million USD | -25.75% |
| 2006 FY | 11.58 Million USD | 171.59% |
| 2006 Q4 | 11.58 Million USD | 37.54% |
| 2006 Q3 | 8.41 Million USD | 145.83% |
| 2006 Q2 | 3.42 Million USD | -8.02% |
| 2006 Q1 | 3.72 Million USD | -12.67% |
| 2005 Q4 | 4.26 Million USD | -38.62% |
| 2005 Q3 | 6.94 Million USD | 0.0% |
| 2005 Q2 | - USD | -100.0% |
| 2005 Q1 | 6.54 Million USD | -6.25% |
| 2005 FY | 4.26 Million USD | -38.92% |
| 2004 Q1 | 3.04 Million USD | 0.15% |
| 2004 FY | 6.98 Million USD | 129.41% |
| 2004 Q3 | 3.01 Million USD | 4.33% |
| 2004 Q2 | 2.88 Million USD | -5.29% |
| 2004 Q4 | 6.98 Million USD | 131.81% |
| 2003 Q4 | 3.04 Million USD | 10.33% |
| 2003 FY | 3.04 Million USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | 2.75 Million USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | -100.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | -100.0% |
| 2001 FY | 1.94 Million USD | -71.92% |
| 2001 Q1 | 6.68 Million USD | -3.35% |
| 2001 Q2 | 4.4 Million USD | -34.14% |
| 2001 Q3 | 2.74 Million USD | -37.68% |
| 2001 Q4 | 1.94 Million USD | -29.2% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | 6.91 Million USD | -29.44% |
| 2000 Q1 | - USD | -100.0% |
| 2000 Q4 | 6.91 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | 9.8 Million USD | 22.65% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q4 | 9.8 Million USD | 0.0% |
| 1998 FY | 7.99 Million USD | -5.46% |
| 1998 Q4 | 7.99 Million USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | 8.45 Million USD | 119.16% |
| 1997 Q1 | - USD | 0.0% |
| 1996 FY | 3.85 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | 16.385% |
| Avicanna Inc. | 1.8 Million CAD | -4758.664% |
| Avant Brands Inc. | 18.7 Million CAD | -368.511% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -55170.229% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -6887.321% |
| Knight Therapeutics Inc. | 69.09 Million CAD | -26.82% |
| MediPharm Labs Corp. | 2.29 Million CAD | -3717.908% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -56429.677% |
| Canopy Growth Corporation | 683.17 Million CAD | 87.174% |
| Willow Biosciences Inc. | 2.15 Million CAD | -3964.054% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 44.908% |